HomeNews

News

  • Chronic Migraine Can Be Treated With Trigeminal Nerve Stimulation

    • May 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novel treatments for Parkinson’s to be discovered by e-Therapeutics & C4X collaboratively

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Medtronic’s Brain Stimulation Therapy for Refractory Epilepsy

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alkermes to Present Clinical Data related to Schizophrenia and Depression at American Psychiatric Association Annual Meeting

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Epilepsy has no impact on pregnancy for women, study finds

    • May 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMD Serono using technology to bring MS experience to life

    • May 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Music makes Alzheimer’s symptoms more manageable, claims recent study

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Vertex Initiates Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New long term data for Copaxone presented by Teva at AAN

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ACADIA Pharmaceuticals reaffirms Nuplazid’s Benefit/Risk Profile

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more